ストックスクリーナーアプリを入手
0.70
1.45%
-0.0103
アフターアワーズ：
.70
前日終値:
$0.7103
開ける：
$0.737
24時間の取引高:
36,232
Relative Volume:
0.28
時価総額：
$15.55M
収益：
$137.00K
当期純損益:
$-24.37M
株価収益率:
-0.471
EPS:
-1.4862
ネットキャッシュフロー:
$-15.97M
1週間 パフォーマンス:
-7.12%
1か月 パフォーマンス:
-18.64%
6か月 パフォーマンス:
-42.15%
1年 パフォーマンス:
-35.78%
1日の値動き範囲:
$0.70
$0.7637
1週間の範囲:
$0.70
$0.7999
52週間の値動き範囲:
$0.70
$2.582
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
名前
Adagio Medical Holdings Inc
セクター
電話
(949) 348-1188
住所
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADGM
Adagio Medical Holdings Inc
|
0.70 | 16.90M | 137.00K | -24.37M | -15.97M | -1.4862 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-14 | 開始されました | Piper Sandler | Overweight |
| 2025-12-02 | 開始されました | Lake Street | Buy |
Adagio Medical Holdings Inc (ADGM) 最新ニュース
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance - Investing.com Canada
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance By Investing.com - Investing.com Australia
Adagio Medical Faces Nasdaq Minimum Bid Price Noncompliance - TipRanks
ADGM Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesSurprise Factor Analysis - newsline.com
Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Adagio Medical (NASDAQ: ADGM) flagged by Nasdaq for sub-$1 bid price and faces delisting risk - Stock Titan
ADGM Q1 2026 Earnings: Wider Loss Misses Estimates as Pre-Revenue Stage ContinuesQuarterly Earnings Report - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Losses Widen; No Revenue YetEarnings Preview - newsline.com
Adagio Medical Holdings Inc (ADGM) Q1 2026 Earnings: EPS Miss Exacerbates Investor Concerns as Pre-Revenue Company Confronts Cash BurnProfit Guidance Range - newsline.com
Adagio Medical Holdings (ADGM) Dips 3.3% as Shares Test Key Support at $0.68New Listing Stocks - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage ContinuesGuidance Accuracy Score - newsline.com
Lucid Capital Markets initiates Adagio Medical stock with buy rating - Investing.com UK
ADGM Initiates Coverage On LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus
Number of shareholders of Adagio Medical Holdings, Inc – NASDAQ:ADGM - TradingView
Lucid Capital Markets initiates Adagio Medical stock with buy rating By Investing.com - Investing.com Canada
Adagio Medical Seeks FDA OK for Heart Device - Orange County Business Journal
ADGM Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue OperationsRevenue Inflection Point - newsline.com
Adagio Medical Holdings (ADGM) Holds Near Support After Marginal DeclineRounding Bottom - newsline.com
Adagio Medical Holdings (ADGM) Holds Steady Near $0.72 as Trading Volume Remains SubduedNews Sentiment - newsline.com
Adagio Medical’s vCLAS System Used to Treat Premature Ventricular Contractions - Medical Product Outsourcing
ADGM Q1 2026 Earnings: EPS Misses Estimates, Shares Slide 10.8%Revenue Inflection Point - newsline.com
ADGM - Finviz
Adagio Medical Holdings (ADGM) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Development CostsProfitability Analysis - newsline.com
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - BioSpace
Adagio Files PMA for Breakthrough Ventricular Ablation System - TipRanks
Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system - Stock Titan
Adagio Medical submits FDA application for VT ablation system By Investing.com - Investing.com Nigeria
Adagio Medical submits FDA application for ventricular tachycardia ablation system - Medical Economics
Adagio Medical submits FDA application for VT ablation system - Investing.com
Adagio Medical submits premarket approval application to FDA for Vclas® ventricular ablation system - marketscreener.com
First purpose-built VT ablation system heads to FDA after 84% shock-free trial - Stock Titan
Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - Sahm
Perceptive Advisors (NASDAQ: ADGM) discloses 55.4% stake via Schedule 13G/A - Stock Titan
Adagio Medical Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TradingKey - TradingKey
Adagio Medical : BofA Securities 2026 Health Care Conference Presentation (9e4df6) - marketscreener.com
Adage Capital (ADGM) reports 1,258,501 shares, 5.67% stake - Stock Titan
Adagio Medical Holdings Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Adagio Medical Holdings, Inc. Q1 2026 10-Q Report: Financials, Risk Factors, and Forward-Looking Statements - Minichart
Adagio Medical Reports Strong Q1 2026 Results and Breakthrough FULCRUM-VT Trial Data for Ultra-Low Temperature Ablation Technology 1 - Minichart
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress - BioSpace
Adagio Medical Holdings, Inc. 1Q 2026: Revenue $5.2M, EPS ($0.31) — 10-Q Summary - TradingView
Adagio Medical (NASDAQ: ADGM) Q1 2026 loss, cash burn and going concern warning - Stock Titan
Adagio Medical Holdings Inc (ADGM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Adagio Medical Holdings (ADGM) price target decreased by 12.50% to 3.57 - MSN
Adagio Medical (ADGM) outlines 2026 director elections and auditor vote - Stock Titan
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference - BioSpace
Adagio Medical heart ablation system shows 84% freedom from shock - MSN
12 Health Care Stocks Moving In Monday's After-Market SessionAdagio Medical Holdings (NASDAQ:ADGM), Ad - Benzinga
Midday Stock Roundup: Willdan Group Drops 14% - Orange County Business Journal
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Adagio Medical Holdings Inc (ADGM) 財務データ
収益
当期純利益
現金流量
EPS
Adagio Medical Holdings Inc (ADGM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Usen Todd | Chief Executive Officer |
Dec 12 '25 |
Buy |
1.09 |
207,315 |
225,973 |
207,315 |
2.43%
大文字化:
|
ボリューム (24 時間):